Stanislav Filip

Hepatic arterial infusion chemotherapy in sarcoma liver metastases: a report of 6 cases.

Transplantation of bone marrow derived progenitor cells in acute myocardial infarction. The first results.

Intraluminal high dose rate brachytherapy of tumorous esophageal stenoses.

Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia.

Differentiation of neural stem cells into cells of oligodendroglial lineage.

Hematopoietic recovery after transplantation CD117+B220- (LACZ*) bone marrow cells in lethally irradiated mice.

Issues and ethical problems of stem cell therapy--where is Hippocrates?

Stem cells and the phenomena of plasticity and diversity: a limiting property of carcinogenesis.

Different solutions used for submucosal injection influenced early healing of gastric endoscopic mucosal resection in a preclinical study in experimental pigs.

Cancer stem cells--new approach to cancerogenensis and treatment.

Expression of intermediate filament nestin in blood vessels of neural and non-neural tissues.

WAA apheresis registry in the Czech Republic: two centers experience.

Homing of lin(-)/CD117(+) hematopoietic stem cells.

Irradiation of adult human dental pulp stem cells provokes activation of p53, cell cycle arrest, and senescence but not apoptosis.

Splenectomy influences homing of transplanted stem cells in bone marrow-ablated mice.

Experience with extracorporeal elimination therapy in myasthenia gravis.

The importance of rheological parameters in the therapy of the dry form of age-related macular degeneration with rheohaemapheresis.

Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments.

Predictors of irinotecan toxicity and efficacy in treatment of metastatic colorectal cancer.

Program of palliative cancer care--our experience.

The role of mesenchymal stem cells in bone repair and regeneration.

The peripheral chimerism of bone marrow-derived stem cells after transplantation: regeneration of gastrointestinal tissues in lethally irradiated mice.

Signaling involved in hair follicle morphogenesis and development.

Multipotent mesenchymal stromal cells in otorhinolaryngology.

NANOTECHNOLOGY - NEW TRENDS IN THE TREATMENT OF BRAIN TUMOURS.

Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients.

Human Multipotent Mesenchymal Stromal Cells in the Treatment of Postoperative Temporal Bone Defect: An Animal Model.

Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression.

Utilizing Autologous Multipotent Mesenchymal Stromal Cells and β-Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial.

Prognostic significance of the frequency of primary cilia in cells of small bowel and colorectal adenocarcinoma.

The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.

Cloning of intronic sequence within DsRed2 increased the number of cells expressing red fluorescent protein.

Association of the combined parameters including the frequency of primary cilia, CD8+ tumor infiltrating lymphocytes and PD-1 expression with the outcome in intestinal cancer.

Directed reprogramming of comprehensively characterized dental pulp stem cells extracted from natal tooth.

The Transplantation of hBM-MSCs Increases Bone Neo-Formation and Preserves Hearing Function in the Treatment of Temporal Bone Defects - on the Experience of Two Month Follow Up.

Comparative Study on the Application of Mesenchymal Stromal Cells Combined with Tricalcium Phosphate Scaffold into Femoral Bone Defects.

Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine.

The toxic effect of cytostatics on primary cilia frequency and multiciliation.

Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer.